Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1977-12-15
1979-04-24
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 12, 260112B, G01N 3316
Patent
active
041512685
ABSTRACT:
Barbituric acid antigens are prepared by coupling 5- or 5,5-substituted barbituric acid to immunogenic carrier materials. In preferred embodiments, proteins are used as the carrier materials and the coupling is effected by an amide linkage between the 5-substituent of the barbituric acid and a carboxyl or amino group of the protein. The resulting antigens produce immunological effects when injected into host animals, including the formation of antibodies specific for 5- and 5,5-substituted barbituric acids. These specific antibodies are useful in bioanalytical techniques for the assay of barbituric acids in biological fluids.
REFERENCES:
usategui-Gomez et al., Clin. Chem., vol. 21, No. 10, Sep. 1975, pp. 1378-1382.
Spiehler et al., Clin. Chem., vol 22, No. 6, Jun. 1976, pp. 749-753.
Cleeland et al., Clin. Chem., vol. 26, No. 6, Jun. 1976, pp. 712-725.
Gould George M.
Hoffmann-La Roche Inc.
Nucker Christine M.
Padgett Benjamin R.
Saxe Jon S.
LandOfFree
Barbituric acid antigens and antibodies specific therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Barbituric acid antigens and antibodies specific therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Barbituric acid antigens and antibodies specific therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1991614